Active surveillance for stage I non-seminomatous germ cell testis tumors: practice and pitfalls.
Raghavan
D
D
Dept. Clinical Oncology, Royal Prince Alfred Hospital, Sydney, N.S.W., Australia.
Boyer
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000000981:diagnostic imaging; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000097:blood / Q000473:pathology* / Q000628:therapy; D011184:Postoperative Period; D011379:Prognosis; D011859:Radiography; D013736:Testicular Neoplasms / Q000097:blood / Q000473:pathology* / Q000628:therapy
D014408:Biomarkers, Tumor